AstraZeneca India launches Qtern, advanced and convenient treatment option for type 2 diabetes… EP News Bureau Feb 21, 2020 Qtern is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus (T2DM)
AstraZeneca India receives marketing permission for QTERN EP News Bureau Sep 26, 2019 Once-daily anti-diabetes treatment for adults with type-2 diabetes, QTERN combines two anti-hyperglycaemic agents with…
